Why the study?
How should new antithrombotic agents be managed perioperatively in patients presenting for procedures in an ambulatory setting?
Population
Patients taking new antiplatelet or anticoagulant agents presenting for surgical or other procedures in an…
Design
Review
Authors
Loading...
Requires individualized perioperative risk assessment for ambulatory procedures; leaves optimal protocols open pending robust trials.
How should new antithrombotic agents be managed perioperatively in patients presenting for procedures in an ambulatory setting?
Perioperative management of new antithrombotic agents requires individualized, multidisciplinary assessment of thrombotic and bleeding risks due to a lack of robust clinical studies.
Gibbs et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: